REFERENCES
- Abraham N. G. Hematopoietic effects of benzene inhalation assessed by long-term bone marrow culture. Environ. Health Perspect 1996; 104(Suppl 6) 1277–1282, [PUBMED], [INFOTRIEVE], [CSA]
- Agency for Toxic Substances and Disease Registry. Toxicological Profile for Formaldehyde. U.S. Department of Health and Human Services, Public Health Service, Washington, DC 1999
- Aksoy M. Hematotoxicity and carcinogenicity of benzene. Environ. Health Perspect 1989; 82: 193–197, [PUBMED], [INFOTRIEVE], [CSA]
- Anderson M., Larson R., Mauritzson N., Schnittger S., Jhanwar S., Pedersen-Bjergaard J. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop. Genes Chromosomes Cancer 2002; 33: 395–400, [CROSSREF], [CSA]
- Appelman L. M., Woutersen R. A., Zwart A. One-year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. J. Appl. Toxicol 1988; 8: 85–90, [PUBMED], [INFOTRIEVE], [CSA]
- Attia S. M., Kliesch U., Schriever-Schwemmer G., Badary O. A., Hamada F. M., Adler I. D. Etoposide and merbarone are clastogenic and aneugenic in the mouse bone marrow micronucleus test complemented by fluorescence in situ hybridization with the mouse minor satellite DNA probe. Environ. Mol. Mutagen 2003; 41(2)99–103, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Austin H., Cole P. Cigarette smoking and leukemia. J. Chron. Disorders 1986; 39(6)417–421, [CROSSREF], [CSA]
- Bar-Sela G., Tsalic M., Gaitini D., Steiner M., Haim N. Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: Association with severe myelotoxicity. Med. Oncol 2003; 20(3)291–294, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bauchinger M., Schmid E. Cytogenetic effects in lymphocytes of formaldehyde workers of a paper factory. Mutat. Res 1985; 158: 195–199, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Beaumont M., Sanz M., Carli P. M., Maloisel X., Thomas L., Fenaux P. Therapy-related acute promyelocytic leukemia. J. Clin. Oncol 2003; 21: 2123–2137, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Berger M. R., Habs M., Schmähl D. Comparative carcinogenic activity of prednimustine, chlorambucil, prenisolone and chlorambucil plus prednisolone in Sprague-Dawley rats. Arch. Geschwulstforsch 1985; 55: 429–442, [PUBMED], [INFOTRIEVE], [CSA]
- Berk P. D., Goldberg J. D., Silverstein M. N., Weinfeld A., Donovan P. B., Ellis J. T., Landaw S. A., Laszlo J., Najean Y., Pisciotta A. V., Wasserman L. R. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N. Engl. J. Med 1981; 304: 441–447, [PUBMED], [INFOTRIEVE], [CSA]
- Bonassi S., Hagmar L., Stromberg U., Montagud A. H., Tinnerberg H., Forni A., Heikkila P., Wanders S., Wilhardt P., Hansteen I. L., Knudsen L. E., Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000; 60(6)1619–1625, [PUBMED], [INFOTRIEVE], [CSA]
- Bowen D. T. Oxidative stress and the myelodysplastic syndromes. Leukocyte Res 2000; 24: 139–140, [CSA]
- Brownson R. C. Cigarette smoking and risk of leukemia. J. Clin. Epidemiol 1989; 42: 1025–1026, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brownson R. C., Novotny T. E., Perry M. C. Cigarette smoking and adult leukemia: A meta-analysis. Arch. Intern. Med 1993; 153: 469–475, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brusamolino E., Anselmo A., Klersy C., et al. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher after combined modality programs than after chemotherapy alone and is correlated with the extent of radio therapy and type and duration of chemotherapy: A case control study. Haematologica 1998; 83: 812–823, [PUBMED], [INFOTRIEVE], [CSA]
- Burkhart K. K., Kulig K. W., McMartin K E. Formate levels following a formalin ingestion. Vet. Hum. Toxicol 1990; 32: 135–137, [PUBMED], [INFOTRIEVE], [CSA]
- Casanova M., Heck Hd'A. Further studies of the metabolic incorporation and covalent binding of inhaled [3H]- and [14C] formaldehyde in Fischer-344 rats: Effects of glutathione depletion. Toxicol. Appl. Pharmacol 1987; 89: 105–121, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Casanova M., Heck H. d'A., Everitt J. I., Harrington W. W., Jr., Popp J. A. Formaldehyde concentrations in the blood of rhesus monkeys after inhalation exposure. Food. Chem. Toxicol 1988; 26: 715–716, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Casanova M., Heck H. d'A., Janszen D. Comments on “DNA-protein crosslinks, a biomarker of exposure to formaldehyde—In vitro and in vivo studies” by Shaham et al. (letter to the Editor). Carcinogenesis 1996; 17: 2097–2101, [PUBMED], [INFOTRIEVE], [CSA]
- Casanova-Schmitz M., Starr T. B., Heck H. d'A. Differentiation between metabolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]- and [3H]formaldehyde. Toxicol. Appl. Pharmacol 1984; 76: 26–44, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cascinu S., Del Ferro E., Ligi M., Graziano F., Catalano G. The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer. Am. J. Clin. Oncol 1997; 20(5)477–478, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Choudhury R. C., Palo A. K., Sahu P. Cytogenetic risk assessment of etopiside from mouse bone marrow. J. Appl. Toxicol 2004; 24(2)115–122, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chu J., Cao S., Ying H., Li D. Experimental study of busulfan-induced leukemia in strain 615 mice [Chin.]. Zhonghua Xueyexue Zazhi 1981; 2: 10–13, [CSA]
- Cierniak A., Papiez M., Kapiszewska M. Modulatory effect of quercetin on DNA damage, induced by etoposide in bone marrow cells and on changes in the activity of antioxidant enzymes in rats. Rocz. Akad. Med. Bialymst. Supp 2004; 1: 167–169, [CSA]
- Coggon D., Harris E. C., Poole J., Palmer K. T. Extended follow-up of a cohort of british chemical workers exposed to formaldehyde. JNCI 2003; 95(21)1608–1615, [PUBMED], [INFOTRIEVE], [CSA]
- Cole P., Axten C. Formaldehyde and leukemia: An improbable causal relationship. Regul. Toxicol. Pharmacol 2004; 40(2)107–112, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Coltman C. A., Dahlberg S. Treatment-related leukemia. N. Engl. J. Med 1990; 322: 52–53, [PUBMED], [INFOTRIEVE], [CSA]
- Conolly R. B., Kimbell J. S., Janszen D., Schlosser P. M., Kalisak D., Preston J., Miller F. J. Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci 2004; 82(1)279–296, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cronkite E. P. Benzene hematotoxicity and leukemogenesis. Blood Cells 1986; 12: 129–137, [PUBMED], [INFOTRIEVE], [CSA]
- Cronkite E. P., Bullis J. E., Inoue T. Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol 1984; 75: 358–361, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cronkite E. P., Drew R. T., Inoue T. Benzene hematotoxicity and leukemogenesis. Am. J. Ind. Med 1985; 7: 447–456, [CSA]
- Cronkite E. P., Drew R. T., Inoue T. Hematotoxicity and carcinogenicity of inhaled benzene. Environ. Health Perspect 1989; 82: 97–108, [PUBMED], [INFOTRIEVE], [CSA]
- Dallas C. E., Mellard D. N., Theiss J. C., Pentecost A. R., Fairchild E. J., 2nd. Distribution of DNA and RNA content in the bone marrow and alveolar macrophages of rats after subchronic inhalation of formaldehyde. Environ. Res 1987; 43(1)191–202, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dallas C. E., Scott M. J., Ward J. B., Jr, Theiss J. C. Cytogenetic analysis of pulmonary lavage and bone marrow cells of rats after repeated formaldehyde inhalation. J. Appl. Toxicol 1992; 12: 199–203, [PUBMED], [INFOTRIEVE], [CSA]
- Dean J. H., Lauer L. D., House R. V., Murray M. J., Stillman W. S., Irons R. D., Steinhagen W. H., Phelps M. C., Adams D. O. Studies of immune function and host resistance in B6C3F1 mice exposed to formaldehyde. Toxicol. Appl. Pharmacol 1984; 72(3)519–529, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Renzo A., Santoro L. F.E., Notaro R., Pane F., Buonaiuto M. R., Luciano L., Rotoli B. Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II. Am. J. Hematol 1999; 60: 300–304, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dunn C. D., Elson L. A. The comparative effect of busulphan (“Myleran”) and aminochlorambucil on haemopoietic colony forming units in the rat. Cell Tissue Kinet 1970; 3(2)131–141, [PUBMED], [INFOTRIEVE], [CSA]
- Eells J. T., McMartin K. E., Black K. Formaldehyde poisoning: Rapid metabolism to formic acid. J. Am. Med. Assoc 1981; 246: 1237–1238, [CROSSREF], [CSA]
- Faiola B., Fuller E. S., Wong V. A., Recio L. Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene. Mutat. Res 2004; 549(1–2)195–212, [PUBMED], [INFOTRIEVE], [CSA]
- Farris G. M., Robinson S. N., Gaido K. W., Wong B. A., Wong V. A., Leonard L., Shah R. Effects of low concentrations of benzene on mouse hematopoietic cells in vivo: A preliminary report. Environ. Health Perspect 1996; 104(Suppl 6)1275–1276, [PUBMED], [INFOTRIEVE], [CSA]
- Farris G. M., Robinson S. N., Gaido K. W., Wong B. A., Wong V. A., Hahn W. P., Shah R. S. Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice. Fundam. Appl. Toxicol 1997; 36(2)119–129, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Feron V. J., Til H. P., Woutersen R. A. Formaldehyde in Sprague-Dawley rats. Toxicol. Ind. Health 1990; 6(6)637–639, [CSA]
- Feron V. J., Til H. P., de Vrijer F., Woutersen R. A., Cassee F. R., van Bladeren P. J. Aldehydes: Occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res 1991; 259(3–4)363–385, [PUBMED], [INFOTRIEVE], [CSA]
- Franks S. J. A mathematical model for the absorption and metabolism of formaldehyde vapour by humans. Toxicol. Appl. Pharmacol 2005; 206(3)309–320, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Freestone J., Bentley A. Case of formaldehyde poisoning. Br. J. Pharm. Pract 1989; 11: 20–21, [CSA]
- Georgieva A. V., Kimbell J. S., Schlosser P. M. A distributed-parameter model for formaldehyde uptake and disposition in the rat nasal lining. Inhal. Toxicol 2003; 15(14)1435–1463, [PUBMED], [INFOTRIEVE], [CSA]
- Greene M. H., Boice J. D., Jr., Greer B. E., Blessing J. A., Dembo A. J. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer. A study of five randomized clinical trials. N. Engl. J. Med 1982; 307: 1416–1421, [PUBMED], [INFOTRIEVE], [CSA]
- Greene M. H., Harris E. L., Gershenson D. M., Malkasian G. D., Jr, Melton L. J., III, Dembo A. J., Bennett J. M., Moloney W. C., Boice J. D., Jr. Melphalan may be a more potent leukemogen than cyclophosphamide. Ann. Intern. Med 1986; 105: 360–367, [PUBMED], [INFOTRIEVE], [CSA]
- Guest I., Uetrecht J. Drugs toxic to the bone marrow that target the stromal cells. Immunopharmacology 2000; 46(2)103–112, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Haas J. F., Kittelmann B., Mehnert W. H., Staneczek W., Mohner M., Kaldor J. M., Day N. E. Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br. J. Cancer 1987; 55: 213–218, [PUBMED], [INFOTRIEVE], [CSA]
- Hagmar L., Bonassi S., Stromberg U., Brogger A., Knudsen L. E., Norppa H., Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998a; 58(18)4117–4121, [PUBMED], [INFOTRIEVE], [CSA]
- Hagmar L., Bonassi S., Stromberg U., Mikoczy Z., Lando C., Hansteen I. L., Montagud A. H., Knudsen L., Norppa H., Reuterwall C., Tinnerberg H., Brogger A., Forni A., Hogstedt B., Lambert B., Mitelman F., Nordenson I., Salomaa S., Skerfving S. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat. Res 1998b; 405(2)171–178, [PUBMED], [INFOTRIEVE], [CSA]
- Hagmar L., Stromberg U., Tinnerberg H., Mikoczy Z. The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis. Int. J. Hyg. Environ. Health 2001; 204(1)43–47, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hagmar L., Stromberg U., Bonassi S., Hansteen I. L., Knudsen L. E., Lindholm C., Norppa H. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: Results from Nordic and Italian cohorts. Cancer Res 2004; 64(6)2258–2263, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hauptmann M., Lubin J. H., Stewart P. A., Hayes R. B., Blair A. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J. Nat. Cancer Inst. 2003; 95(21)1615–1623, [PUBMED], [INFOTRIEVE], [CSA]
- He J. L., Jin L. F., Jin H. Y. Detection of cytogenetic effects in peripheral lymphocytes of students exposed to formaldehyde with cytokinesis-blocked micronucleus assay. Biomed. Environ. Sci. 1998; 11: 87–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Heath C. W. Cigarette smoking and hematopoietic cancer. JNCI 1990; 82: 1800–1801, [PUBMED], [INFOTRIEVE], [CSA]
- Heck H., Casanova M. The implausibility of leukemia induction by formaldehyde: A critical review of the biological evidence on distant-site toxicity. Reg. Toxicol. Pharmacol 2004; 40(2)92–106, [CROSSREF], [CSA]
- Heck H. D., Casanova-Schmitz M., Dodd P. B., Schachter E. N., Witek T. J., Tosun T. Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am. Ind. Hyg. Assoc. J 1985; 46: 1–3, [PUBMED], [INFOTRIEVE], [CSA]
- Hoffmann L., Moller P., Pedersen-Bjergaard J., Wagge A., Pedersen M., Hirsch F. R. Therapy-related acute promyelocytic leukemia with t(15;17)(q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature. Ann. Oncol 1995; 6: 781–788, [PUBMED], [INFOTRIEVE], [CSA]
- Hsieh L. L., Liou S. H., Chiu L. L., Chen Y. H. Glutathione S-transferase (GST) M1 and GST T1 genotypes and hematopoietic effects of benzene exposure. Arch. Toxicol 1999; 73(2)80–82, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Huff J. E., Haseman J. K., DeMarini D. M. Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F mice. Environ. Health Perspect 1989; 82: 125–163, [PUBMED], [INFOTRIEVE], [CSA]
- Infante P. F., Rinsky R. A., Wagoner J. K. Leukemia in benzene workers. Lancet 1977; 2: 76–78, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- International Agency for Research on Cancer (IARC). Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. IARC Monogr. Eval. Carcinogenic Risks to Humans. World Health Organization. 1974
- International Agency for Research on Cancer IARC. Some antineoplastic and immunosuppressive agents. IARC Monogr. Eval. Carcinogen. Risks Huma. 1981; 26
- International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. Supp. 7, World Health Organization, International Agency for Research on Cancer, LyonFrance 1987; 38–74
- International Agency for Research on Cancer. X-radiation and gamma (γ)-radiation. IARC Monogr. Eval. Carcinogen. Risks Huma 2000; 75, [CSA]
- International Agency for Research on Cancer. Formaldehyde, 2 butoxyethanol and 1-tert-butoxy-2-propanol. IARC Monogr. Eval. Carcinogen. Risks Huma 2004; 82: 2–9, [CSA]
- International Programme for Chemical Safety. Principles for the Assessment of Risks to Human Health from Exposure to Chemicals. Environmental Health Criteria No. 210, World Health Organization. 1999
- Irons R. D., Stillman W. S. The effects of benzene and other leukaemogenic agents on haematopoietic stem and progenitor cell differentiation. Eur. J. Haematol. Suppl 1996a; 60: 119–124, [PUBMED], [INFOTRIEVE], [CSA]
- Irons R. D., Stillman W. S. The process of leukemogenesis. Environ. Health Perspect 1996b; 104(Suppl. 6)1239–1246, [PUBMED], [INFOTRIEVE], [CSA]
- Jagetia G. C., Aruna R. Elevation of micronuclei frequency in mouse bone marrow treated with various doses of teniposide (VM-26). Toxicol. Lett 1999; 104(3)203–210, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jandl J. H. Blood, Textbook of Hematology. Little, Brown & Company, Boston 1997
- Johannsen F. R., Levinskas G. J., Tegeris A. S. Effects of formaldehyde in the rat and dog following oral exposure. Toxicol. Lett 1986; 30: 1–6, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kamata E., Nakadate M., Uchida O. Results of a 28-month chronic inhalation toxicity study of formaldehyde in male Fischer-344 rats. J. Toxicol. Sci 1997; 22: 239–254, [PUBMED], [INFOTRIEVE], [CSA]
- Kerns W. D., Pavkov K. L., Donofrio D. J. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res 1983b; 43: 4382–4391, [PUBMED], [INFOTRIEVE], [CSA]
- Kitaeva L. V., Kitaev E. M., Pimenova M. N. Cytopathic and cytogenetic effects of chronic inhalation of formaldehyde on germ and marrow cells of the female rat. Tsitologiia 1990; 32: 1212–1216, [PUBMED], [INFOTRIEVE], [CSA]
- Koppel C., Baudisch H., Schneider V. Suicidal ingestion of formalin with fatal complications. Intens. Care Med 1990; 16: 212–214, [CROSSREF], [CSA]
- Korte J. E., Hertz-Picciotto I., Schulz M. R., Ball L. M., Duell E. J. The contribution of benzene to smoking-induced leukemia. Environ. Health Perspect 2000; 108(4)333–339, [PUBMED], [INFOTRIEVE], [CSA]
- Leone G., Mele L., Pulsoni A., Equitani F., Pagano L. The incidence of secondary leukemias. Haematologica 1999; 84: 937–945, [PUBMED], [INFOTRIEVE], [CSA]
- Lin H., She Y. H., Cassileth B. R., Sirotnak F., Cunningham Rundles S. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int. Immunopharmacol 2004; 4(1)91–99, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Linet M. S., Yin S. N., Travis L. B., Li C. Y., Zhang Z. N., Li D. G., Rothman N., Li G. L., Chow W. H., Donaldson J., Dosemeci M., Wacholder S., Blot W. J., Hayes R. B., Wang Y. Z., Dai T. R., Chao X. J., Qing C., Jiang Z. L., Zhang W. U., Ye P. Z., Kou Q. R., Fan Y. H., Zhang X. C. Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Environ. Health Perspect 1996; 104(Suppl. 6)1353–1364, [PUBMED], [INFOTRIEVE], [CSA]
- Lohrmann H. P., Schreml W. Cytotoxic drugs and the granulopoietic system. Recent Results Cancer Res 1982; 81: 1–222, [PUBMED], [INFOTRIEVE], [CSA]
- Ma T. H., Harris M. M. Review of the genotoxicity of formaldehyde. Mutat. Res 1988; 196(1)37–59, [PUBMED], [INFOTRIEVE], [CSA]
- Marsh G. M., Youk A. O. Reevaluation of mortality risks from leukemia in the formaldehyde cohort study of the National Cancer Institute. Regul. Toxicol. Pharmacol 2004; 40(2)113–124, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McLaughlin J. K., Hrubec Z., Linet M. S., Heineman E. F., Blot W. J., Fraumeni J. F., Jr. Cigarette smoking and leukemia. JNCI 1989; 81: 1262–1263, [PUBMED], [INFOTRIEVE], [CSA]
- Medinsky M. A., Kenyon E. M., Seaton M. J., Schlosser P. M. Mechanistic considerations in benzene physiological model development. Environ. Health Perspect 1996; 104(Suppl. 6)1399–404, [PUBMED], [INFOTRIEVE], [CSA]
- Merk O., Speit G. Significance of formaldehyde-induced DNA-protein crosslinks for mutagenesis. Environ. Mol. Mutagen 1998; 32: 260–268, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mondello C., Giorgi R., Nuzzo F. Chromosomal effects of methotrexate on cultured human lymphocytes. Mutat. Res 1984; 139(2)67–70, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Morley A., Blake J. An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan. Blood 1974; 44: 49–56, [PUBMED], [INFOTRIEVE], [CSA]
- Nakanomyo H., Hiraoka M., Shiraya M. Mutagenicity tests of etoposide and teniposide. J. Toxicol. Sci. Suppl 1986; 1: 301–10, [CSA]
- Natarajan A. T., Darroudi F., Bussman C. J., van Kesteren-van Leeuwen A. C. Evaluation of the mutagenicity of formaldehyde in mammalian cytogenetic assays in vivo and vitro. Mutat. Res 1983; 122(3–4)355–360, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- National Toxicology Program. Seventh Annual Report on Carcinogens: 1994 Summary. National Toxicology Program. Benzene, U.S. DHHS, PHS, Washington, DC 1994
- Nelson N., Levine R. J., Albert R. E., Blair A. E., Griesemer R. A., Landrigan P. J., Stayner L. T., Swenberg J. A. Contribution of formaldehyde to respiratory cancer. Environ. Health Perspect 1986; 70: 23–35, [PUBMED], [INFOTRIEVE], [CSA]
- Niculescu R., Kalf G. F. A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process. Arch. Toxicol 1995; 69(3)141–148, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ochs J., Rodman J., Abromowitch M., Kavanagh R., Harris M., Yalowich J., Rivera G. K. A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study. J. Clin. Oncol 1991; 9(1)139–144, [PUBMED], [INFOTRIEVE], [CSA]
- Oredipe O. A., Furbert-Harris P. M., Laniyan I., Green W. R., Griffin W. M., Sridhar R. Mice primed with swainsonine are protected against doxorubicin-induced lethality. Cell Mol. Biol 2003; 49(7)1089–1099, [PUBMED], [INFOTRIEVE], [CSA]
- Park D. J., Koeffler H. P. Therapy-related myelodysplastic syndromes. Semin. Hematol 1996; 33: 256–273, [PUBMED], [INFOTRIEVE], [CSA]
- Parke D. V. Personal reflections on 50 years of study of benzene toxicology. Environ. Health Perspect 1996; 104(Suppl. 6)1123–1128, [PUBMED], [INFOTRIEVE], [CSA]
- Pedersen-Bjergaard J., Ersbøll J., Sørensen H. M., Keiding N., Larsen S. O., Philip P., Larsen M. S., Schultz H., Nissen N. I. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. Ann. Intern. Med 1985; 103: 195–200, [PUBMED], [INFOTRIEVE], [CSA]
- Pedersen-Bjergaard J., Andersen M. K., Christiansen D. H., Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 2002; 99(6)1909–1912, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pereira M. A., Chang L. W., McMillan L. Battery of short-term tests in laboratory animals to corroborate the detection of human population exposures to genotoxic chemicals. [Abstract]. Environ. Mutagen 1982; 4: 317, [CSA]
- Petru E., Berger M. R., Schmahl D. Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence. Cancer Lett 1989; 44(3)221–226, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pinkerton L. E., Hein M. J., Stayner L. T. Mortality among a cohort of garment workers exposed to formaldehyde: An update. Occup. Environ. Med 2004; 61(3)193–200, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Preston R. J., Hoffmann G. R. Genetic toxicology. Casarett & Doull's Toxiclology: The Basic Science of Poisons, 6th ed., C. D. Klaassen. McGraw-Hill, New York 2001
- Pui C. H., Ribeiro R. C., et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N. Engl. J. Med 1991; 325: 1682–1687, [PUBMED], [INFOTRIEVE], [CSA]
- Reimer R. R., Hoover R., Fraumeni J. F., Jr, Young R. C. Acute leukemia after alkylating-agent therapy of ovarian cancer. N. Engl. J. Med 1977; 297: 177–181, [PUBMED], [INFOTRIEVE], [CSA]
- Quievryn G., Zhitkovich A. Loss of DNA-protein crosslinks from formaldehyde-exposed cells occurs through spontaneous hydrolysis and an active repair process linked to proteosome function. Carcinogenesis 2000; 21: 1573–1580, [PUBMED], [INFOTRIEVE], [CSA]
- Schmahl D., Habs M. Experimental carcinogenesis of antitumour drugs. Cancer Treat. Rev 1978; 5(4)175–184, [PUBMED], [INFOTRIEVE], [CSA]
- Seidel H. J., Barthel E., Zinser D. The hematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene. Exp. Hematol 1989; 17: 300–303, [PUBMED], [INFOTRIEVE], [CSA]
- Severson R. K., Davis S., Heuser L., Daling J. R., Thomas D. B. Cigarette smoking and acute nonlymphocytic leukemia. Am. J. Epidemiol 1990; 132: 418–422, [PUBMED], [INFOTRIEVE], [CSA]
- Shaham J., Bomstein Y., Meltzer A., Kaufman Z., Palma E., Ribak J. DNA–protein crosslinks, a biomarker of exposure to formaldehyde-in vitro and in vivo studies. Carcinogenesis 1996; 17: 121–125, [PUBMED], [INFOTRIEVE], [CSA]
- Shaham J., Gurvich R., Kaufman Z. Sster chromatid exchange in pathology staff occupationally exposed to formaldehyde. Mutat. Res 2002; 15: 115–123, [CSA]
- Smit E. F., Splinter T. A., Kok T. C. A phase I study of daily oral teniposide for 20 days. Semin. Oncol. Suppl 1992; 6: 40–42, [CSA]
- Snyder C. A., Goldstein B. D., Sellakumar A. R. Evidence for hematotoxicity and tumorigenesis in rats exposed to 100 ppm benzene. Am. J. Ind. Med 1984; 5: 429–434, [PUBMED], [INFOTRIEVE], [CSA]
- Snyder R. Recent developments in the understanding of benzene toxicity and leukemogenesis. Drug Chem. Toxicol 2000; 23(1)13–25, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Snyder R., Hedli C. C. An overview of benzene metabolism. Environ Health Perspect 1996; 104(Suppl. 6)1165–1171, [PUBMED], [INFOTRIEVE], [CSA]
- Snyder R., Kalf G. F. A perspective on benzene leukemogenesis. Crit. Rev. Toxicol 1994; 24: 177–209, [PUBMED], [INFOTRIEVE], [CSA]
- Soffritti M., Maltoni C., Maffei R., Biagi R. Formaldehyde: An experimental multipotential carcinogen. Toxicol. Ind. Health 1989; 5(5)699–630, [PUBMED], [INFOTRIEVE], [CSA]
- Soffritti M., Belpoggi F., Lenzi A., Maltoni C. Results of long-term carcinogenicity studies of chlorine in rats. Ann. NY Acad. Sci 1997; 26(837)189–208, [CSA]
- Soffritti M., Belpiggi F., Lambertini L., Lauriola M., Padovani M., Maltoni C. Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats. Ann. NY Acad. Sci 2002; 982: 87–105, [PUBMED], [INFOTRIEVE], [CSA]
- Speit G., Schütz P., Merk O. Induction and repair of formaldehyde-induced DNA–protein crosslinks in repair-deficient human cell lines. Mutagenesis 2000; 15: 85–90, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stillman W. S., Varella-Garcia M., Irons R. D. The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19− bone marrow cells. Exp. Hematol 2000; 28(2)169–176, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stoner G. D., Shimkin M. B., Kniazeff A. J., Weisburger J. H., Weisburger E. K., Gori G. B. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res 1973; 33: 3069–3085, [PUBMED], [INFOTRIEVE], [CSA]
- Stott H., Stephens R. J., Fox W., Roy D. C. 5-Year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. B. J. Cancer 1976; 34(2)167–173, [CSA]
- Suruda A., Schulte P., Boeniger M., Hayes R. B., Livingston G. K., Steenland K. Cytogenetic effects of formaldehyde exposure in students of mortuary science. Cancer Epidemiol. Biomarkers Prev 1993; 2: 453–460, [PUBMED], [INFOTRIEVE], [CSA]
- Swenberg J. A., Kerns W. D., Mitchell R. I., Gralla E. J., Pavkov K. L. Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor. Cancer Res 1980; 40(9)3398–402, [PUBMED], [INFOTRIEVE], [CSA]
- Takahashi M., Hasegawa R., Furukawa F., Toyoda K., Sato H., Hayashi Y. Effects of ethanol, potassium metabisulfite, formaldehyde and hydrogen peroxide on gastric carcinogenesis in rats after initiation with N-methyl-N′-nitrosoguanidine. Jpn. J. Cancer Res 1986; 77: 118–124, [PUBMED], [INFOTRIEVE], [CSA]
- Thomson E. J., Shackleton S., Harrington J. M. Chromosome aberrations and sister-chromatid exchange frequencies in pathology staff occupationally exposed to formaldehyde. Mutat. Res. 1984; 141: 89–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Til H. P., Woutersen R. A., Feron V. J. Evaluation of the oral toxicity of acetaldehyde and formaldehyde in a 4-week drinking-water study in rats. Food Chem. Toxicol 1988; 26: 447–452, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Til H. P., Woutersen R. A., Feron V. J., Hollanders V. H., Falke H. E., Clary J. J. Two-year drinking-water study of formaldehyde in rats. Food Chem. Toxicol 1989; 27(2)77–87, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- To H., Ohdo S., Shin M., Uchimaru H., Yukawa E., Higuchi S., Fuijimura A., Kobayashi E. Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in rats. J. Pharm. Pharmacol 2003; 55(6)803–810, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tobe M., Natio K., Kurokawa Y. Chronic toxicity study on formaldehyde administered orally to rats. Toxicology 1989; 56: 79–86, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Trainor K. J., Morley A. A. Screening of cytotoxic drugs for residual bone marrow damage. J. Natl. Cancer Inst 1976; 57(6)1237–1239, [PUBMED], [INFOTRIEVE], [CSA]
- Trainor K. J., Seshadri R. S., Morley A. A. Residual marrow injury following cytotoxic drugs. Leukocyle. Res 1979; 3(4)205–210, [CROSSREF], [CSA]
- U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum. U.S. EPA, Washington, Dc 2005, EPA/630/P-03/001B
- U.S. Environmental Protection Agency, National Center for Environmental Assessment. Chemical and Radiation Leukemogenesis in Humans and Rodents and the Value of Rodent Models for Assessing Risks of Lymphohematopoietic Cancers. ORD, U.S. EPA, Washington, DC. 1997, EPA600R-97/090
- U.S. Food and Drug Administration. Indirect food additives, additives, adjuvants, production aids, and sanitizers. Fed. Reg 1998; 63: 35134–35135, [CSA]
- Valeriote F. A., Tolen S. J. Survival of hematopoietic and lympha colony-forming cells in vivo following the administration of a variety of alkylating agents. Cancer Res 1972; 32(3)470–476, [PUBMED], [INFOTRIEVE], [CSA]
- Van Putten L. M., Lelieveld P. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard. Eur. J. Cancer 1971; 7(1)11–16, [PUBMED], [INFOTRIEVE], [CSA]
- Vargova M., Wagnerova J., Liskova A. Subacute immunotoxicity study of formaldehyde in male rats. Drug Chem. Toxicol 1993; 16: 255–275, [PUBMED], [INFOTRIEVE], [CSA]
- Vasudeva N., Anand C. Cytogenetic evaluation of medical students exposed to formaldehyde vapor in the gross anatomy dissection laboratory. J. Am. Coll. Health 1996; 44: 177–179, [PUBMED], [INFOTRIEVE], [CSA]
- Walker and Bole. Augmented incidence of neoplasia in femaler New Zealand black/New Zealand white mice treated with long term cyclophosphamide. J. Lab. Clin. Med 1971; 78: 978–979, [CSA]
- Weisburger E. K. Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents. Cancer 1977; 40(4 Suppl.)1935–1949, [PUBMED], [INFOTRIEVE], [CSA]
- Woutersen R. A., Appleman L. M., Wilmer J. W. Subchronic (13-week) inhalation toxicity study of formaldehyde in rats. J. Appl. Toxicol. 1987; 7: 43–49, [PUBMED], [INFOTRIEVE], [CSA]
- Yager J. W., Cohn K. L., Spear R. C., Fisher J. M., Morse L. Sister-chromatid exchanges in lymphocytes of anatomy students exposed to formaldehyde-embalming solution. Mutat. Res 1986; 174: 135–139, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ying C. J., Yan W. S., Zhao M. Y., Ye X. L., Xie H., Yin S. Y. Micronuclei in nasal mucosa, oral mucosa and lymphocytes in students exposed to formaldehyde vapor in anatomy class. Biomed. Environ. Sci 1997; 10: 451–455, [PUBMED], [INFOTRIEVE], [CSA]
- Ying C. J., Ye X. L., Xie H., Yan W. S., Zhao M. Y., Xia T. Lymphocyte subsets and sister-chromatid exchanges in the students exposed to formaldehyde vapor. Biomed. Environ. Sci 1999; 12: 88–94, [PUBMED], [INFOTRIEVE], [CSA]
- Yoon B. I., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kim D. Y., Inoue T. Mechanism of action of benzene toxicity: cell cycle suppression in hemopoietic progenitor cells (CFU-GM). Exp. Hematol 2001; 29(3)278–285, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhitkovich A., Costa M. A simple, sensitive assay to detect DNA–protein crosslinks in intact cells and in vivo. Carcinogenesis 1992; 13: 1485–1489, [PUBMED], [INFOTRIEVE], [CSA]